SynteractHCR (Formerly Known As Synteract)

5759 Fleet Street
Suite 100
Carlsbad
California
92008
United States

Tel: 760-268-8200
Fax: 760-929-1419

Email: Trisha.VonderReith@synteracthcr.com

About SynteractHCR (Formerly Known As Synteract)

SynteractHCR is a full-service contract research organization with a successful two-decade plus track record supporting biotechnology, medical device and pharmaceutical companies in all phases of clinical development. SynteractHCR has conducted Phase I-IV studies on six continents and in more than 60 countries, offering expertise across multiple therapeutic areas and with notable depth in oncology, CNS, infectious disease, endocrinology, cardiovascular and respiratory, among other indications. With its “Shared Work – Shared Vision” philosophy and ICD+ approach, SynteractHCR provides customized services collaboratively and cost effectively, ensuring on-time delivery of quality data so clients get to decision points faster.

47 articles about SynteractHCR (Formerly Known As Synteract)

CRO Industry Veteran John Potthoff Joins SynteractHCR Board of Directors

10/26/2017

SynteractHCR announced the appointment of industry veteran John Potthoff to its Board of Directors, effective immediately.
SynteractHCR Moves To New Headquarters In Carlsbad, San Diego County, California

10/4/2017
SynteractHCR Announces New Chief Medical Officer Dr. Frank Santoro

8/10/2017
SynteractHCR CEO Steve Powell And Vice President Etienne Drouet Named To PharmaVOICE 100’s Most Inspiring People In Life Sciences

8/2/2017
SynteractHCR Names a New CEO

7/17/2017
SynteractHCR And The GOG Foundation Enter Into Agreement To Work Together In Supporting Gynecologic Oncology Research Studies

6/1/2017
SynteractHCR Adds Another Three Senior Executives To Management Team With Both U.S. And International Clinical Trials Operations Experience

4/19/2017
SynteractHCR Continues To Show International Clinical Trial Expertise By Participating In European Conferences This Spring

4/12/2017
SynteractHCR Experts Slated To Speak At Leading Drug Development Conferences

2/1/2017
SynteractHCR Release: Company Expands With Four New Experts Added To Global Leadership Team

1/18/2017
SynteractHCR Expands Its Conference Speaking Engagements In October

10/11/2016
SynteractHCR Continues To Bolster Senior Leadership Ranks To Match Global Growth

10/6/2016
SynteractHCR Proves Industry Expertise Through Conference And Webinar Education

9/1/2016
SynteractHCR Presenting And Exhibiting At DIA 2016 Annual Meeting In Philadelphia

6/14/2016
Gryphon Investors Exits SynteractHCR Investment

5/26/2016
Amulet Capital Partners, LP Announces Acquisition Of SynteractHCR

5/26/2016
SynteractHCR Honored With Five Life Science Leader 2016 CRO Leadership Awards

5/10/2016
SynteractHCR Experts Continue Presentations At U.S. And European Events Focused On Outsourcing In Clinical Trials

5/4/2016
SynteractHCR Global Nordic ePharma Day And Pediatric Drug Development Conferences Medical And Regulatory Affairs Expert Dr. Martine Dehlinger-Kremer Speaking At In April

4/13/2016
SynteractHCR Team Participates In San Diego “Fight For Air” Climb Sponsored By The American Lung Association

3/31/2016